A 44-bed research clinical for inVentiv Health opened at the University of Miami Health Science and Technology Park on Tuesday.
The Burlington, Massachusetts-based company has 32 employees in the new space, which will be used for Phase I clinical trials to help commercialize new drugs and biopharmaceuticals.
“The Miami clinic is purpose-built to optimize trials for clients from the start,” said Dr. Michael McKelvey, president, inVentiv Health Clinical Division and executive VP, inVentiv Health.
